当前位置: 首页 > 期刊 > 《中国药房》 > 2025年第10期
编号:2444271
NF- ??κB 信号通路在急性肺损伤中的作用及中药干预研究进展
http://www.100md.com 2025年9月28日 中国药房 2025年第10期
    

    中图分类号 R85 文献标志码 A 文章编号 1001-0408(05)10-177-06

    DOI 10.6039/j.issn.1001-0408.05.10.

    Research progress on the role NF- κB signaling pathway in acute lung injury and TCM intervention

    LIU Fuli1,BA Yuanming2(1. ; 2. Dept. )

    ABSTRACT Acute lung injury (ALI) is a common clinical inflammatory respiratory emergency with high morbidity and mortality,for which there is no effective and safe therapeutic drug. Nuclear factor- κB (NF- κB ),as a classic inflammatory signaling pathway,can interact with upstream and downstream regulatory factors such as Toll-like receptor 4(TLR4),mitogenactivated protein kinase (MAPK), nucleotide-binding domain leucine-rich repeat and pyrin domain-containing receptor 3 (NLRP3),high mobility group box-1 protein 1 (HMGB1),to jointly affect ALI. This review summarizes the latest research findings in recent years regarding the treatment ALI through traditional medicine(TCM)interventions targeting NF- κB signaling pathways. It has been found that a variety TCM monomers (danshensu methyl ester ......

您现在查看是摘要页,全文长 23872 字符